Fate Therapeutics (NASDAQ: FATE) announced that Wendy Levin, M.D., M.S. will join the Company as Vice President, Clinical Development and ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE